Your browser doesn't support javascript.
loading
Pharmacotherapy for Obesity.
Saunders, Katherine H; Shukla, Alpana P; Igel, Leon I; Kumar, Rekha B; Aronne, Louis J.
Afiliação
  • Saunders KH; Comprehensive Weight Control Center, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, 1165 York Avenue, New York, NY 10065, USA. Electronic address: kph2001@med.cornell.edu.
  • Shukla AP; Comprehensive Weight Control Center, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, 1165 York Avenue, New York, NY 10065, USA.
  • Igel LI; Comprehensive Weight Control Center, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, 1165 York Avenue, New York, NY 10065, USA.
  • Kumar RB; Comprehensive Weight Control Center, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, 1165 York Avenue, New York, NY 10065, USA.
  • Aronne LJ; Comprehensive Weight Control Center, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, 1165 York Avenue, New York, NY 10065, USA.
Endocrinol Metab Clin North Am ; 45(3): 521-38, 2016 09.
Article em En | MEDLINE | ID: mdl-27519128
ABSTRACT
Successful treatment of obesity requires a multidisciplinary approach including diet, exercise and behavioral modification. As lifestyle changes are not sufficient for some patients, pharmacologic therapies should be considered as adjuncts to lifestyle interventions. In this article, we review clinical indications, mechanisms of action, dosing/administration, side effects, drug interactions and contraindications for the six most widely prescribed obesity medications. We also summarize the efficacy data from phase 3 trials which led to drug approval. As multiple agents are sometimes required for clinically significant weight loss, the future of obesity medicine will likely involve combinations of agents in addition to behavioral counseling.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Antiobesidade / Obesidade Limite: Humans Idioma: En Revista: Endocrinol Metab Clin North Am Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Antiobesidade / Obesidade Limite: Humans Idioma: En Revista: Endocrinol Metab Clin North Am Ano de publicação: 2016 Tipo de documento: Article